Literature DB >> 1678229

Long-term follow-up of lichen planus.

C Irvine1, F Irvine, R H Champion.   

Abstract

Several large series of patients with lichen planus were reported some 30 years ago but no recent large surveys have been published. In this study, detailed enquiry was made into the natural history of the disease in 214 patients followed up 8 to 12 years after presentation to the Dermatology Department. The key findings from this study showed that the mean age of onset of lichen planus in males was significantly lower than in females (40.3 years in males compared with 46.4 years in females, p less than 0.05). The main eruption of lichen planus cleared within one year in 68% of the patients but we found a higher recurrence rate than in previous series at 49%. Many patients suffered from persistent brown staining many years after the rash had cleared.

Entities:  

Mesh:

Year:  1991        PMID: 1678229

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  5 in total

Review 1.  Treatment of lichen planus.

Authors:  G F Oliver; R K Winkelmann
Journal:  Drugs       Date:  1993-01       Impact factor: 9.546

2.  Spectrum of non-infectious erythematous, papular and squamous lesions of the skin.

Authors:  Grace D' Costa; Bhavana M Bharambe
Journal:  Indian J Dermatol       Date:  2010 Jul-Sep       Impact factor: 1.494

3.  An Unusual Presentation of Lichen Planus.

Authors:  Pranjali Sharma
Journal:  Cureus       Date:  2021-11-06

4.  Incidence of Lichen Planus and Subsequent Mortality in Finnish Women.

Authors:  Pia Halonen; Maija Jakobsson; Oskari Heikinheimo; Mika Gissler; Eero Pukkala
Journal:  Acta Derm Venereol       Date:  2020-10-28       Impact factor: 3.875

5.  Immunoexpression of interleukin-22 and interleukin-23 in oral and cutaneous lichen planus lesions: a preliminary study.

Authors:  Jun Chen; Jinqiu Feng; Xiangdong Chen; Hui Xu; Zengtong Zhou; Xuemin Shen; Zhexuan Bao; Wei Liu; Zhengyu Shen
Journal:  Mediators Inflamm       Date:  2013-11-26       Impact factor: 4.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.